Placebo effects can act as powerful pain relievers. Although the ethics of therapeutic placebo use are highly controversial, recent evidence suggests that medical providers frequently utilize placebo treatments and patients may be open to these interventions in certain contexts. This investigation used a patient-centered approach to answer essential questions about placebo treatment acceptability. People with chronic musculoskeletal pain completed a placebo survey in which they rated their knowledge of placebo and its efficacy for alleviating pain, evaluated the acceptability of placebo analgesic interventions across several unique medical contexts, and responded to 6 different patient-physician treatment scenarios to assess the role of deception and placebo effectiveness on mood and provider trust. Results showed that participants had limited knowledge of placebo and its efficacy for alleviating pain. Placebo acceptability was highly dependent on the context of the intervention, as placebo treatments were considered acceptable when used as complementary/adjunct treatments and when no other established treatments were available. Also, an analgesic placebo response mitigated the negative consequences of deception by improving provider trust and decreasing negative mood. These findings suggest that, contrary to popular belief, patients may be rather pragmatic in their appraisals of placebo treatment acceptability, and may consider a variety of treatments/contexts as ethically permissible for managing their pain. This is the first study of its kind to quantify perceptions of placebo analgesia knowledge and efficacy among individuals with chronic pain, and to assess the role of different medical contexts in treatment acceptability.
Introduction
The effectiveness of most medical interventions is derived partially from contextual or nonspecific factors, commonly referred to as placebo effects [12] . These effects have demonstrated remarkable potency for the alleviation of pain, and under certain circumstances, placebos have produced effect sizes indistinguishable from established medications [24, 42] , surgeries [30] , and other analgesic treatments [25, 40, 43] . With clearly defined neurobiological [2, 31] and psychological [7, 32, 37] underpinnings, the placebo analgesic response is one of the most well-understood models of placebo [8, 17, 34] .
Despite considerable advances in understanding placebo mechanisms and effects, debate persists regarding the acceptability of therapeutic placebo use [28] . Whereas the ethics of placebo-controlled/randomized-controlled trials (RCTs) have been well established [11, 22, 27, 44] , the placebo treatment debate continues to incite disagreement among health care providers, bioethicists, and researchers [4] . Interventional placebo use opponents tout a variety of arguments, including that placebo use would damage the provider-patient relationship and/or cause psychological distress [10] . These arguments are primarily driven by placebos' association with deceptive means and presumed negative consequences of deceiving patients [29] . Medical associations rarely adopt policies/guidelines regarding clinical placebo use, although some organizations prohibit covert use [3] . However, health care providers frequently use placebo interventions, often unbeknownst to patients [13, 14, 18, 26, 39] . 
